Order Article Reprints

Mahmoud SH, Khalil AA, Abo Shama NM, El Sayed MF, Soliman RA, Hagag NM, Yehia N, Naguib MM, Arafa A-S, Ali MA, et al. Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses. Vaccines. 2023; 11(9):1397. https://doi.org/10.3390/vaccines11091397

Mahmoud, Sara H., Ahmed A. Khalil, Noura M. Abo Shama, Marwa F. El Sayed, Reem A. Soliman, Naglaa M. Hagag, Nahed Yehia, Mahmoud M. Naguib, Abdel-Sattar Arafa, Mohamed A. Ali, and et al. 2023. "Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses" Vaccines 11, no. 9: 1397. https://doi.org/10.3390/vaccines11091397

Mahmoud, S. H., Khalil, A. A., Abo Shama, N. M., El Sayed, M. F., Soliman, R. A., Hagag, N. M., Yehia, N., Naguib, M. M., Arafa, A.-S., Ali, M. A., El-Safty, M. M., & Mostafa, A. (2023). Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses. Vaccines, 11(9), 1397. https://doi.org/10.3390/vaccines11091397